$374.30
+0 (+0%)
At Close: Oct 16, 2025
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
02:08pm, Monday, 24'th Oct 2022 Benzinga
Upgrades
Guggenheim upgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Sell to Neutral. Teladoc Health earned $0.44 in the second quarter, compared to $0.86 in the year-ago quarter.
American Express To Plunge Around 9%? Plus This Analyst Slashes PT On Verizon
11:50am, Monday, 24'th Oct 2022 Benzinga
Citigroup cut the price target on American Express Company (NYSE: AXP) from $130 to $128. American Express shares rose 0.6% to $140.87 in pre-market trading.
Wells Fargo cut Ares Capital Corporati
ANSYS (ANSS) Solutions Used By ZeroAvia to Reduce Air Pollution
02:03pm, Friday, 21'st Oct 2022 Zacks Investment Research
ANSYS (ANSS) simulation solutions are used by ZeroAvia to support the temperature, safety, certification, stress, fatigue and lifting aspects of hydrogen-electric engine design.
Where Ansys Stands With Analysts
01:11pm, Monday, 17'th Oct 2022 Benzinga
Over the past 3 months, 6 analysts have published their opinion on Ansys (NASDAQ:ANSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's
Ansys to Release Third Quarter 2022 Earnings on November 2, 2022
04:30pm, Thursday, 13'th Oct 2022
PITTSBURGH , Oct. 13, 2022 /PRNewswire/ -- ANSYS, Inc. (NASDAQ: ANSS) announced today that the Company expects to release its third quarter earnings on Wednesday, November 2, 2022, after the market
ANSYS (ANSS) Set to Acquire C&R Technologies: Key Takeaways
04:40pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
C&R Technologies' portfolio of solutions is complementary to ANSYS' (ANSS) suite of 3D thermal, fluid flow and mission simulation solutions.
ANSYS (ANSS) Set to Acquire C&R Technologies: Key Takeaways
02:17pm, Wednesday, 12'th Oct 2022
C&R Technologies' portfolio of solutions is complementary to ANSYS' (ANSS) suite of 3D thermal, fluid flow and mission simulation solutions.
Reasons to Retain ANSYS (ANSS) Stock in Your Portfolio
05:04pm, Friday, 07'th Oct 2022 Zacks Investment Research
ANSYS' (ANSS) performance is benefiting from strength in its product portfolio as well as synergies from acquisitions.
Reasons to Retain ANSYS (ANSS) Stock in Your Portfolio
02:18pm, Friday, 07'th Oct 2022
ANSYS' (ANSS) performance is benefiting from strength in its product portfolio as well as synergies from acquisitions.
Synopsys (SNPS) Introduces Code Sight Plugin for IntelliJ
10:56am, Friday, 07'th Oct 2022 Zacks Investment Research
Synopsys' (SNPS) Code Sight Standard Edition plugin for IntelliJ IDEA is likely to help software developers address security defects in real time as they code on IntelliJ.
Synopsys (SNPS) & Samsung Foundry Team Up on 3nm Process Design
02:15pm, Thursday, 06'th Oct 2022 Zacks Investment Research
In collaboration with Samsung Foundry, Synopsys (SNPS) enables 3nm GAA technology for demanding mobile, high-performance computing and artificial intelligence application design flows.
Tracking Ron Baron's BAMCO Portfolio - Q2 2022 Update
04:53am, Monday, 03'rd Oct 2022 Seeking Alpha
Ron Baron's 13F portfolio value decreased from $40.75B to $31.14B this quarter. Click here to read more about BAMCO's holdings and trades for Q2 2022.
'Reshoring' is poised to boost U.S. companies bringing business back home. Shares of these 17 companies will benefit.
02:11pm, Saturday, 24'th Sep 2022 MarketWatch
Automation, construction and chip companies will be the recipients of billions of dollars in capital-expenditure spending.
Where Ansys Stands With Analysts
05:06pm, Monday, 19'th Sep 2022 Benzinga
Within the last quarter, Ansys (NASDAQ:ANSS) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
1
0
Last 30D
0
1
0
Expert Ratings for Ansys
03:12pm, Monday, 19'th Sep 2022 Benzinga
Analysts have provided the following ratings for Ansys (NASDAQ:ANSS) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
1
0
Last 30D
Sign In
Buy ANSS